Inhibikase Therapeutics, Inc. (IKT) Institutional Ownership

Institutions by Trading Activity

Ownership Statistics

0Shares Outstanding
30,759,590Shares held by institutions
$48,907,748Value of institutional holdings
60.77%Institutional ownership %
-1.45%Shares Changed QoQ
48No. of institutional investors

Shares Owned by Institutions

Shares Purchased/Sold by Institutions

Ownership Summary

Inhibikase Therapeutics, Inc. (NASDAQ:IKT) has 73 institutional investors that have filed 13F reports for the period ending December 2025.

73 Institutional Holders

30,759,590 Total Shares Held
Download Data
Owner Name Date Shares Held Change (QoQ) Change (%) Value (USD)
BlackRock, Inc. 31 Dec, 2025 0 230,388 7.49% $0.00
Blackstone Inc. 31 Dec, 2025 0 3,300,000 125.08% $0.00
ADAR1 Capital Management, LLC 31 Dec, 2025 0 10,880,295 207.34% $0.00
Barclays Plc 31 Dec, 2025 0 9,217 10.77% $0.00
PERCEPTIVE ADVISORS LLC 31 Dec, 2025 0 0 0.00% $0.00
Sands Capital Alternatives, LLC 31 Dec, 2025 0 2,068,965 18.89% $0.00
VANGUARD GROUP INC 31 Dec, 2025 0 1,285,265 39.26% $0.00
Soleus Capital Management, L.P. 31 Dec, 2025 0 4,550,000 71.94% $0.00
Nantahala Capital Management, LLC 31 Dec, 2025 0 1,739,292 79.42% $0.00
Fairmount Funds Management LLC 31 Dec, 2025 0 2,500,000 40.82% $0.00
Stonepine Capital Management, LLC 31 Dec, 2025 0 1,613,128 219.47% $0.00
Trails Edge Capital Partners, LP 31 Dec, 2025 0 6,178,124 0.00% $0.00
Ameriprise Financial Inc 31 Dec, 2025 0 1,376,395 0.00% $0.00
Siren, L.L.C. 31 Dec, 2025 0 5,850,000 0.00% $0.00
CITADEL ADVISORS LLC 31 Dec, 2025 0 1,171,960 1,635.22% $0.00
Commodore Capital LP 31 Dec, 2025 0 0 0.00% $0.00
GEODE CAPITAL MANAGEMENT, LLC 31 Dec, 2025 0 15,665 1.41% $0.00
Squadron Capital Management LLC 31 Dec, 2025 0 4,225,000 0.00% $0.00
State Street Corp 31 Dec, 2025 0 47,100 9.28% $0.00
Saturn V Capital Management LP 31 Dec, 2025 0 3,856,799 0.00% $0.00